{"ticker": {"uuid": "b0a0195e-5a9e-4d08-ab45-a285004ded26", "symbol": "HMD", "name": "HeraMED Limited", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "HeraMED Seeks ASX Quotation for 1.15 Million New Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPdkJ1WXVQYzRydlJCck1WNzBXSkQ3Rkw2UzJHMlM0a0RuNW1uUkZxZDBjaEQ4MEVETTZWNkZLcWdxeDJyMFI2eVVCRG9Cc2o4WFNSOFd2Wm5IMjVxQjQycW02dWNMRlc0RWdkcThwNlVLXzByNDBPenF6ZklLU3NrUUZQRnpJUFhTREhxalNXamNBazlFbnVIVEFNME9iRXB0aVJTMERsSWJHMHM?oc=5", "source_name": "TipRanks", "published_at": "2026-06-19T05:50:38+00:00", "published_display": "19 Jun 2026 05:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeraMed Issues 15 Million Performance Rights and 4 Million Options to Directors Following AGM Approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxQeTJPUkVkbmNGOTR0RTJhanpZNWhtMDdKOWZyM0hLeWpNMGJOSTJESDVHeEktQUkwQjFEaTN3UjdSWHk4R185MVJtZ2ZSRXNKMlQ4cmVUVDAyR2pObkVOemdYVFo2WnhGcjJOaWZIWlY5UGxSeDNPenIybWwyV21TbGV2ODZ0UzJ3M0RnREFHcGh4c051WlpWeGlBYngzd2U4YWZMd0RnUGFEVHNQakRXYWE2Q3laamlLdnlyQ25qVEItWDhpdjczQWRJN3pHTUVUX0dxWFFtWXJ6Q01u?oc=5", "source_name": "Kalkine", "published_at": "2026-06-15T06:26:46+00:00", "published_display": "15 Jun 2026 06:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeraMED Accelerates U.S. Push as Philips Partnership and Lee Health Pilot Gain Traction", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxQTlZxZUtvWXJGZDJPRm8zRVJ4OFZZWmxvS21jQjRJNEFHUFJaVXR4cW55RVdlanJNZUE0QXd1TWQ5Q3hzVEFSZGZOYmVvSS1LNFpkY012N0lSZTBmS0locUp2ellHd25NbW9TUXlkZHkteE9GWHAwdUVfbkJpeG5KZzFnNU1WUkY5WTMtUkY2a0huaXV1OVlnU1VxTC14SVEzYW4zdnBJZC1sUy1KV1pRYnNoY1hzWmZVc3VNbTdydjMtQ3kxQ3lKcm1HM2hYMG1oVGFiaQ?oc=5", "source_name": "TipRanks", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insights: HeraMED Ltd (ASX:HMD)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTFBaS0p6QlBicExLcmZGQWg3cmZBRXlEZDl4QTBDckJTWUV0ZnJ6RmRRXzVxSVY0US1EaUNsYUdHT1U3a2lTRUV4Q3lRQjhEakRl?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-10-30T15:18:39+00:00", "published_display": "30 Oct 2025 15:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HMD Stock Price and Chart \u2014 ASX:HMD", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE1mRUVRQTN3Um1IS25CaVZod3BRWFhEWTBIck95OVZiQjY3UzBwMG5aZDVqRVRrWWUzRWwtRnZZTWlWTG5wOUthUC1uNi1HeTVXYkEwcE9ZSQ?oc=5", "source_name": "TradingView", "published_at": "2021-04-30T07:00:00+00:00", "published_display": "30 Apr 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Heramed Stock Price Forecast. Should You Buy HMD.AX?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiS0FVX3lxTE9fNmVYcllqWDJQbzNTTGRmdy03NU9nQ0VYUG44Z2VfYVpCS2M2RkNVUFVRRXRZaC1aTWo0U21SQ1VUeHlrSjB3VlJ6MA?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-19T05:39:50+00:00", "published_display": "19 Dec 2020 05:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeraMED Limited (ASX: HMD) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxON2R5TE5LSk5qUTRRSkNGZWNrc3hyMlNQSGZJXzQ0S192a1dkNnV5NmhyQmlsNnJaalQtWUJuajBfb3ZRMDZnekJLVXhwSXJnWFV5SE0wX1RMNVYxckZxR3JEXzBKaG0yVVVZeklDQTNtSXg1ZklVNWhSb1BrQ3dZR09fTS1tQmhS?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2020-02-03T07:09:24+00:00", "published_display": "03 Feb 2020 07:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeraMED Limited (ASX:HMD)", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE4zNU5IRV9IcHV0em9WNVVnQkw3Wl9TcVFpZ2l1ak1oMmg1OXJrbENrZ3RTQnRhN3lEQmFQZ0lzWkJlbURpVjN0a0J4aklRckE2Wnl4U2xFQzJEdG45cTNORWxXSy1LVF9EdWRiOGgxcmtNQ0ZGS2ZnWg?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2019-09-24T16:40:22+00:00", "published_display": "24 Sep 2019 16:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of HeraMED Ltd (ASX:HMD)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE1vakZld05ra2hXTGRxck9Rckx0dnNtZ1NQR3FlRV9Vd2dvSjNqck9RejZ2cVRLOE45Wng4dVlLVjFEb1BNRHdLMVQteUNUWDE1d3djV1owYWVnVm9pUHhwbDVZNkl3UQ?oc=5", "source_name": "TradingView", "published_at": "2018-12-21T09:09:22+00:00", "published_display": "21 Dec 2018 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeraMED raises NIS 16m in Australian IPO - Globes", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxPNjZWRmhnd3dzZEpIWFhySEhsUWpJMjNpa3p2cXNDWkl3UElVSV9EZEN2VUpIZlRrZ3RqbkRfbjBTeFE0cHVxa1p1b00wbXBkSG01eXpkNjB3aVBreDJqMC1qSHR0V3ZwcmtZQURSb1VuMXI3T2RudzdybTlyZGJMX0U5UkpDS1NnZUg2RXQycw?oc=5", "source_name": "Israel Business News", "published_at": "2018-12-11T08:00:00+00:00", "published_display": "11 Dec 2018 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeraMED files NIS 16m prospectus in Australia - Globes", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNOGhJN0lEemhlT3psWVlaR3ZnbC1oVGZkNTU1b3VJVWlsVEtwX0hPM3lEbVB1U2ViaXR3eGpyd3RzU3FIdU5fdzJyUjQ1MHZBOEgxTHdsbkpLMGdxc29ER2FjcmtKVkpmNml3b2U2WExTOVpuaTZFdnBsa00wTkgzckFOUGFfRk44SFJ0ZjN4UEpRVXFvbGc?oc=5", "source_name": "Israel Business News", "published_at": "2018-10-31T07:00:00+00:00", "published_display": "31 Oct 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "HeraMED Seeks ASX Quotation for 1.15 Million New Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPdkJ1WXVQYzRydlJCck1WNzBXSkQ3Rkw2UzJHMlM0a0RuNW1uUkZxZDBjaEQ4MEVETTZWNkZLcWdxeDJyMFI2eVVCRG9Cc2o4WFNSOFd2Wm5IMjVxQjQycW02dWNMRlc0RWdkcThwNlVLXzByNDBPenF6ZklLU3NrUUZQRnpJUFhTREhxalNXamNBazlFbnVIVEFNME9iRXB0aVJTMERsSWJHMHM?oc=5", "source_name": "TipRanks", "published_at": "2026-06-19T05:50:38+00:00", "published_display": "19 Jun 2026 05:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeraMed Issues 15 Million Performance Rights and 4 Million Options to Directors Following AGM Approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxQeTJPUkVkbmNGOTR0RTJhanpZNWhtMDdKOWZyM0hLeWpNMGJOSTJESDVHeEktQUkwQjFEaTN3UjdSWHk4R185MVJtZ2ZSRXNKMlQ4cmVUVDAyR2pObkVOemdYVFo2WnhGcjJOaWZIWlY5UGxSeDNPenIybWwyV21TbGV2ODZ0UzJ3M0RnREFHcGh4c051WlpWeGlBYngzd2U4YWZMd0RnUGFEVHNQakRXYWE2Q3laamlLdnlyQ25qVEItWDhpdjczQWRJN3pHTUVUX0dxWFFtWXJ6Q01u?oc=5", "source_name": "Kalkine", "published_at": "2026-06-15T06:26:46+00:00", "published_display": "15 Jun 2026 06:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeraMED Accelerates U.S. Push as Philips Partnership and Lee Health Pilot Gain Traction", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxQTlZxZUtvWXJGZDJPRm8zRVJ4OFZZWmxvS21jQjRJNEFHUFJaVXR4cW55RVdlanJNZUE0QXd1TWQ5Q3hzVEFSZGZOYmVvSS1LNFpkY012N0lSZTBmS0locUp2ellHd25NbW9TUXlkZHkteE9GWHAwdUVfbkJpeG5KZzFnNU1WUkY5WTMtUkY2a0huaXV1OVlnU1VxTC14SVEzYW4zdnBJZC1sUy1KV1pRYnNoY1hzWmZVc3VNbTdydjMtQ3kxQ3lKcm1HM2hYMG1oVGFiaQ?oc=5", "source_name": "TipRanks", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insights: HeraMED Ltd (ASX:HMD)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTFBaS0p6QlBicExLcmZGQWg3cmZBRXlEZDl4QTBDckJTWUV0ZnJ6RmRRXzVxSVY0US1EaUNsYUdHT1U3a2lTRUV4Q3lRQjhEakRl?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-10-30T15:18:39+00:00", "published_display": "30 Oct 2025 15:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HMD Stock Price and Chart \u2014 ASX:HMD", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE1mRUVRQTN3Um1IS25CaVZod3BRWFhEWTBIck95OVZiQjY3UzBwMG5aZDVqRVRrWWUzRWwtRnZZTWlWTG5wOUthUC1uNi1HeTVXYkEwcE9ZSQ?oc=5", "source_name": "TradingView", "published_at": "2021-04-30T07:00:00+00:00", "published_display": "30 Apr 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Heramed Stock Price Forecast. Should You Buy HMD.AX?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiS0FVX3lxTE9fNmVYcllqWDJQbzNTTGRmdy03NU9nQ0VYUG44Z2VfYVpCS2M2RkNVUFVRRXRZaC1aTWo0U21SQ1VUeHlrSjB3VlJ6MA?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-19T05:39:50+00:00", "published_display": "19 Dec 2020 05:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeraMED Limited (ASX: HMD) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxON2R5TE5LSk5qUTRRSkNGZWNrc3hyMlNQSGZJXzQ0S192a1dkNnV5NmhyQmlsNnJaalQtWUJuajBfb3ZRMDZnekJLVXhwSXJnWFV5SE0wX1RMNVYxckZxR3JEXzBKaG0yVVVZeklDQTNtSXg1ZklVNWhSb1BrQ3dZR09fTS1tQmhS?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2020-02-03T07:09:24+00:00", "published_display": "03 Feb 2020 07:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeraMED Limited (ASX:HMD)", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE4zNU5IRV9IcHV0em9WNVVnQkw3Wl9TcVFpZ2l1ak1oMmg1OXJrbENrZ3RTQnRhN3lEQmFQZ0lzWkJlbURpVjN0a0J4aklRckE2Wnl4U2xFQzJEdG45cTNORWxXSy1LVF9EdWRiOGgxcmtNQ0ZGS2ZnWg?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2019-09-24T16:40:22+00:00", "published_display": "24 Sep 2019 16:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of HeraMED Ltd (ASX:HMD)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE1vakZld05ra2hXTGRxck9Rckx0dnNtZ1NQR3FlRV9Vd2dvSjNqck9RejZ2cVRLOE45Wng4dVlLVjFEb1BNRHdLMVQteUNUWDE1d3djV1owYWVnVm9pUHhwbDVZNkl3UQ?oc=5", "source_name": "TradingView", "published_at": "2018-12-21T09:09:22+00:00", "published_display": "21 Dec 2018 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeraMED raises NIS 16m in Australian IPO - Globes", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxPNjZWRmhnd3dzZEpIWFhySEhsUWpJMjNpa3p2cXNDWkl3UElVSV9EZEN2VUpIZlRrZ3RqbkRfbjBTeFE0cHVxa1p1b00wbXBkSG01eXpkNjB3aVBreDJqMC1qSHR0V3ZwcmtZQURSb1VuMXI3T2RudzdybTlyZGJMX0U5UkpDS1NnZUg2RXQycw?oc=5", "source_name": "Israel Business News", "published_at": "2018-12-11T08:00:00+00:00", "published_display": "11 Dec 2018 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeraMED files NIS 16m prospectus in Australia - Globes", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNOGhJN0lEemhlT3psWVlaR3ZnbC1oVGZkNTU1b3VJVWlsVEtwX0hPM3lEbVB1U2ViaXR3eGpyd3RzU3FIdU5fdzJyUjQ1MHZBOEgxTHdsbkpLMGdxc29ER2FjcmtKVkpmNml3b2U2WExTOVpuaTZFdnBsa00wTkgzckFOUGFfRk44SFJ0ZjN4UEpRVXFvbGc?oc=5", "source_name": "Israel Business News", "published_at": "2018-10-31T07:00:00+00:00", "published_display": "31 Oct 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 79, "total_relevant": 11, "sentiment_summary": {"positive": 3, "negative": 0, "neutral": 8, "score": 54, "total": 11, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 85, "events": [{"event": "general", "label": "Market update", "weight": 4.4, "count": 8}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 3, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.04, "latest_week": "2026-06-19", "one_week_move": -5.3, "four_week_move": -10.0, "twelve_week_move": -21.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.168678, "market_dynamics_buy_signal": false, "relative_strength": 0.213326, "fair_value_gap": 16.2, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 43.0347, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-5.3% over one week, -10.0% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 65, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TipRanks", "count": 2}, {"label": "TradingView", "count": 2}, {"label": "intelligentinvestor.com.au", "count": 2}, {"label": "Israel Business News", "count": 2}, {"label": "Kalkine", "count": 1}, {"label": "smallcaps.com.au", "count": 1}, {"label": "StockInvest.us", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 11}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 8}, {"label": "Regulatory and legal", "count": 1}, {"label": "Deals and strategy", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "85/100 classification confidence."}, {"label": "Company focus", "value": "11", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-5.3% over one week, -10.0% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "HeraMED Seeks ASX Quotation for 1.15 Million New Shares"}], "updated_at": "2026-06-23T00:18:12.363146+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}